Exempt Chemical Preparations Under the Controlled Substances Act

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Exempt Chemical Preparations Application	Form	Modified	Available
Exempt Chemical Preparations Application	Form	Modified	Available
1117-0058 Exempt Chemicals Supporting Statement_07.30.2024.docx	Supporting Statement A	Uploaded 2024-11-20	Available
1117-0058 Exempt Chemicals Supporting Statement_07.30.2024.docx	Supporting Statement A	Uploaded 2024-11-20	Repair queued
21 CFR 1308.23(c) application requirements.docx	Supplementary Document	Uploaded 2021-07-12	Available
21 CFR 1308.23(c) application requirements.docx	Supplementary Document	Uploaded 2021-07-12	Repair queued
21 USC 811 (g)(3).docx	Supplementary Document	Uploaded 2021-07-12	Available
21 USC 811 (g)(3).docx	Supplementary Document	Uploaded 2021-07-12	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
248294	Exempt Chemical Preparations Application	Form	Modified	Exempt Chemical Preparations Application
248294	Exempt Chemical Preparations Application	Form	Modified

ICR Details

OMB Control No: 1117-0058	ICR Reference No: 202407-1117-002
Status: Active	Previous ICR Reference No: 202107-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Exempt Chemical Preparations Under the Controlled Substances Act
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/14/2025
Retrieve Notice of Action (NOA)	Date Received in OIRA: 11/20/2024
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2028	36 Months From Approved	01/31/2025
Responses	2,093	0	2,093
Time Burden (Hours)	2,093	0	2,093
Cost Burden (Dollars)	0	0	113,169

---

Abstract: Pursuant to 21 U.S.C. 811(g)(3)(B), DEA may exempt from specific provisions of the Controlled Substances Act any compound, mixture, or preparation containing any controlled substance, which is not for administration to a human being or animal, and which is packaged in a certain manner, so that as packaged it does not present any significant potential for abuse. In accordance with 21 CFR 1308.23(f), the Administrator (or the Deputy Assistant Administrator), at any time, may: revoke or modify any exemption granted pursuant to 21 CFR 1308.23; modify or revoke the criteria by which exemptions are granted; and modify the scope of exemptions. This application will provide a uniform way for registrants to request the exemptions.

---

Authorizing Statute(s): US Code: 21 USC 811 Name of Law: Controlled Substances Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 68205	08/23/2024
30-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 85239	10/25/2024
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Exempt Chemical Preparations Application	N/A	Exempt Chemical Preparations Application

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	2,093	2,093	0	0	0	0
Annual Time Burden (Hours)	2,093	2,093	0	0	0	0
Annual Cost Burden (Dollars)	0	113,169	0	-113,169	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $244,631

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/20/2024

---